Table: Immuno Biological Lab -2018/19 group results

Immuno-Biological Laboratories

14/05/2019 07:30

May 14 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2019    Mar 31, 2018    Mar 31, 2020      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          781 mln         758 mln         991 mln                 
               (+3.0 pct)      (+2.3 pct)      (+27.0 pct)               
  Operating   loss 173 mln     loss 48 mln    loss 391 mln               
  Recurring   loss 155 mln     loss 49 mln    loss 550 mln               
  Net
  Net         loss 167 mln     loss 52 mln    loss 565 mln               
  EPS        loss 19.82 yen   loss 7.01 yen  loss 64.76 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T